skip to main content

THE RELATIONSHIP BETWEEN CLINICAL STAGE AND THERAPEUTIC RESPONSE AFTER COMPLETE RADIOCHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA WHO TYPE III IN NGOERAH HOSPITAL DENPASAR

*Ida Bagus Gede Hendra Kusuma  -  Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Bali, Indonesia, Indonesia
I Gde Ardika Nuaba  -  Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Bali, Indonesia, Indonesia
Sari Wulan Dwi Sutanegara  -  Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Bali, Indonesia, Indonesia
Komang Andi Dwi Saputra  -  Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Bali, Indonesia, Indonesia
Made Lely Rahayu  -  Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Bali, Indonesia, Indonesia
Agus Rudi Asthuta  -  Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Bali, Indonesia, Indonesia
Open Access Copyright 2025 Ida Bagus Gede Hendra Kusuma, I Gde Ardika Nuaba, Sari Wulan Dwi Sutanegara, Komang Andi Dwi Saputra, Made Lely Rahayu, Agus Rudi Asthuta
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Citation Format:
Abstract

Background: Nasopharyngeal cancer (NPC) is the fourth most common cancer in Indonesia, with WHO type III being the most aggressive yet highly responsive to radiochemotherapy. Various factors can impact treatment outcomes. Objective: To determine the relationship between clinical stage and therapeutic response after complete radiochemotherapy in patients with WHO type III NPC. Methods: This retrospective cohort study evaluated 148 WHO type III NPC patients who completed radiochemotherapy at Ngoerah Hospital (2020–2023). Patients were classified into early-stage (stage I-II, n=74) and advanced-stage (stage III-IVB, n=74) groups. Three months post-treatment, therapeutic response was assessed using RECIST 1.1 criteria (CR, PR, PD, SD) following re-staging procedures (imaging and diagnostics). A comparative analysis examined CR rates between the two groups and the relationship between clinical stage and treatment response. Results: The overall therapeutic response in this study was 27.7% CR, 22.3% PR, 25.0% SD, and 25.0% SD. Pre-radiochemotherapy clinical stage was significantly associated with the therapeutic response after complete radiochemotherapy. WHO type III NPC patients with advanced stage had a 37 times higher risk of non-CR than patients with early stage after adjustment for age, gender, and main symptoms (adjusted RR = 37.404; IK95% 8.308-168.393; p<0.001). Conclusion: Clinicians should prioritize early detection in high-risk patients with WHO type III NPC, as advanced-stage cases have poorer therapeutic responses. Patient education is crucial to ensure understanding of the disease progression and therapy prognosis, especially for advanced stages.

Fulltext View|Download
Keywords: Clinical stage; Nasopharyngeal carcinoma; Radiochemotherapy; RECIST; Therapy response

Article Metrics:

  1. Jiromaru R, Nakagawa T, Yasumatsu R. Advanced Nasopharyngeal Carcinoma: Current and Emerging Treatment Options. Cancer Manag Res. 2022;14:2681–9
  2. Korkmaz M, Eryılmaz MK, Koçak MZ, Demirkıran A, Karaağaç M, Artaç M. The goal of primary therapy in non-metastatic nasopharyngeal cancer should be radiological complete response. Egypt J Otolaryngol. 2022;38(1):1–7
  3. Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, et al. Nasopharyngeal carcinoma in indonesia: Epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer. 2012;31(4):185–96
  4. Romdhoni AC, Alkaff FF, Kahdina M, Masturina M, Ramadhani R, Salamah S. Clinical presentation of nasopharyngeal Carcinoma in East Java, Indonesia. Pakistan J Med Heal Sci. 2020;14(3):942–6
  5. Jicman (Stan) D, Niculet E, Lungu M, Onisor C, Rebegea L, Vesa D, et al. Nasopharyngeal carcinoma: A new synthesis of literature data (Review). Exp Ther Med. 2021;23(2):1–7
  6. Sinha S, Winters R, Gajra A. Nasopharyngeal cancer. St

Last update:

No citation recorded.

Last update:

No citation recorded.